Intravesical Gemcitabine: A Phase 1 and Pharmacokinetic Study
Author:
Publisher
Elsevier BV
Subject
Urology
Reference25 articles.
1. Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup;Solsona;J. Urol.,1999
2. A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary carcinoma of the bladder;Oosterlinck;J. Urol.,1993
3. A Systematic Overview of Chemotherapy Effects in Urothelial Bladder Cancer;Nilsson;Acta Oncol.,2001
4. Intravesical chemotherapy prophylaxis in primary superficial bladder cancer: a meta-analysis of 3703 patients from 11 randomized trials;Huncharek;J. Clin. Epidemiol.,2000
5. A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer;Pawinski;J. Urol.,1996
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluation of toxicities for intravesical drugs in phase 1 bladder cancer trials;Cancer;2022-10-19
2. Adjuvant therapies for non-muscle-invasive bladder cancer: advances during BCG shortage;World Journal of Urology;2022-01-27
3. Fabrication and Evaluation of Gemcitabine-loaded Alginate Microspheres: A Potential Approach for Treatment of Various Carcinomas;Indian Journal of Pharmaceutical Education and Research;2022-01-12
4. Evolving Treatment in Non-muscle-Invasive Bladder Cancer;Urologic Oncology;2022
5. Knockdown of RRM1 with Adenoviral shRNA Vectors to Inhibit Tumor Cell Viability and Increase Chemotherapeutic Sensitivity to Gemcitabine in Bladder Cancer Cells;International Journal of Molecular Sciences;2021-04-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3